Development of dendritic-cell lineages - PubMed (original) (raw)
Review
Development of dendritic-cell lineages
Li Wu et al. Immunity. 2007 Jun.
Free article
Abstract
Dendritic cells (DCs) are a heterogenous population of bone-marrow-derived immune cells. Although all DCs share a common ability to process and present antigen to naive T cells for the initiation of an immune response, they differ in surface markers, migratory patterns, localization, and cytokine production. DCs were originally considered to be myeloid cells, but recent findings have demonstrated that DCs can develop not only from myeloid- but also from lymphoid-committed progenitors. The common feature of the progenitors capable of developing into DCs is the surface expression of Flt3 receptor. The development of different populations of DCs is differentially regulated by various transcription factors and cytokines. This review summarizes the recent advances made in the field of DC development.
Similar articles
- Development of dendritic cell system.
Wu L, Dakic A. Wu L, et al. Cell Mol Immunol. 2004 Apr;1(2):112-8. Cell Mol Immunol. 2004. PMID: 16212897 Review. - Origin and development of dendritic cells.
Liu K, Nussenzweig MC. Liu K, et al. Immunol Rev. 2010 Mar;234(1):45-54. doi: 10.1111/j.0105-2896.2009.00879.x. Immunol Rev. 2010. PMID: 20193011 Review. - Dendritic cell subtypes and in vitro generation of dendritic cells.
Jacobs B, Wuttke M, Papewalis C, Seissler J, Schott M. Jacobs B, et al. Horm Metab Res. 2008 Feb;40(2):99-107. doi: 10.1055/s-2007-1022561. Horm Metab Res. 2008. PMID: 18283627 Review. - T cell priming by tissue-derived dendritic cells: new insights from recent murine studies.
Sillé FC, Visser A, Boes M. Sillé FC, et al. Cell Immunol. 2005 Oct;237(2):77-85. doi: 10.1016/j.cellimm.2005.10.004. Epub 2005 Dec 19. Cell Immunol. 2005. PMID: 16360134 Review. - Dendritic cell lineage, plasticity and cross-regulation.
Liu YJ, Kanzler H, Soumelis V, Gilliet M. Liu YJ, et al. Nat Immunol. 2001 Jul;2(7):585-9. doi: 10.1038/89726. Nat Immunol. 2001. PMID: 11429541 Review.
Cited by
- Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy.
Wang Y, Liu C, Fang C, Peng Q, Qin W, Yan X, Zhang K. Wang Y, et al. Nanomicro Lett. 2024 Sep 30;17(1):30. doi: 10.1007/s40820-024-01533-y. Nanomicro Lett. 2024. PMID: 39347944 Free PMC article. Review. - The interaction of innate immune and adaptive immune system.
Wang R, Lan C, Benlagha K, Camara NOS, Miller H, Kubo M, Heegaard S, Lee P, Yang L, Forsman H, Li X, Zhai Z, Liu C. Wang R, et al. MedComm (2020). 2024 Sep 15;5(10):e714. doi: 10.1002/mco2.714. eCollection 2024 Oct. MedComm (2020). 2024. PMID: 39286776 Free PMC article. Review. - Expression and Localization Profiles of Tight Junction Proteins in Immune Cells Depend on Their Activation Status.
Voges L, Weiß F, Branco AT, Fromm M, Krug SM. Voges L, et al. Int J Mol Sci. 2024 Apr 29;25(9):4861. doi: 10.3390/ijms25094861. Int J Mol Sci. 2024. PMID: 38732086 Free PMC article. - Network-based screening identifies sitagliptin as an antitumor drug targeting dendritic cells.
Ng II, Zhang J, Tian T, Peng Q, Huang Z, Xiao K, Yao X, Ng L, Zeng J, Tang H. Ng II, et al. J Immunother Cancer. 2024 Mar 7;12(3):e008254. doi: 10.1136/jitc-2023-008254. J Immunother Cancer. 2024. PMID: 38458637 Free PMC article. - Negative Vaccination Strategies for Promotion of Transplant Tolerance.
Tunbridge MJ, Luo X, Thomson AW. Tunbridge MJ, et al. Transplantation. 2024 Aug 1;108(8):1715-1729. doi: 10.1097/TP.0000000000004911. Epub 2024 Feb 16. Transplantation. 2024. PMID: 38361234 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous